1000 mg, soft capsules
Omega-3 acid ethyl esters 90
Omacor contains highly purified omega-3 polyunsaturated fatty acids.
Omacor belongs to a group of medicines that lower cholesterol and triglyceride levels.
Omacor is used:
If any of the above applies to you, do not take the medicine and consult your doctor.
Before taking Omacor, consult your doctor or pharmacist:
If you are taking medicines that prevent blood clots in arteries, such as warfarin, you may need to have additional blood tests and adjust the dose of your blood-thinning medicines.
Tell your doctor or pharmacist about all the medicines you are taking, or have recently taken, and any you plan to take.
Capsules should be taken with meals. This will help avoid stomach and gastrointestinal upset.
Caution should be exercised when using Omacor in patients over 70 years old.
Omacor should not be used in children.
Omacor should not be used during pregnancy and breastfeeding, unless your doctor decides it is absolutely necessary.
Before taking any medicine, consult your doctor or pharmacist.
It is unlikely that Omacor will affect your ability to drive or use machines.
Omacor contains soybean oil. If you are allergic to peanuts or soy, do not take Omacor.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The usual dose is two capsules per day, as recommended by your doctor.
If the medicine does not have the desired effect, your doctor may increase the dose to four capsules per day.
Accidental overdose is unlikely to cause concern, as it usually does not require special treatment. However, you should consult your doctor or pharmacist.
If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. In this case, take the next dose at the scheduled time. Do not take a double dose (twice the dose recommended by your doctor) to make up for the missed dose.
If you have any doubts about taking the medicine, consult your doctor or pharmacist.
Like all medicines, Omacor can cause side effects, although not everybody gets them.
The following side effects may occur during treatment with Omacor:
Other side effects that have occurred in a small number of people, but whose frequency is unknown
If any of the side effects get worse, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and label.
The expiry date refers to the last day of the month.
Do not store above 25°C. Do not freeze.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is omega-3 acid ethyl esters.
1000 mg of omega-3 acid ethyl esters 90 contains 460 mg of ethyl ester of eicosapentaenoic acid (EPA) and 380 mg of ethyl ester of docosahexaenoic acid (DHA) (these substances are called omega-3 polyunsaturated fatty acids), and as an antioxidant 4 mg of D-alpha-tocopherol (mixed with vegetable oil, e.g., soybean oil).
Capsule shell: gelatin, glycerol, purified water, medium-chain triglycerides, lecithin (soy).
Omacor is available as transparent, soft capsules containing a light yellow oil.
The pack contains 20, 28, or 100 capsules.
Not all pack sizes may be marketed.
BASF AS
Lilleakerveien 2B
NO-0283 Oslo
P.O. Box 420; NO-1327 Lysaker
Norway
BASF AS
Framnesveien 41
NO-3222 Sandefjord
Norway
Pierre Fabre Médicament Production
Le Payrat
46000 Cahors
France
representative of the marketing authorization holder:
Viatris Healthcare Sp. z o.o.
tel. 22 546 64 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.